Tackling Chronic Wounds: Hull's Wound Innovation Institute and the Future of Wound Care

The Naked Scientists explore the global and NHS-led burden of chronic wounds, linking them to diabetes and obesity, and highlight Hull’s Wound Innovation Institute as a new hub for diagnostics, data, and therapies. Guests discuss current gaps, cost drivers, and the promise of technologies such as 3D bioprinting and buffy coat therapies to improve healing and reduce downstream complications.

• Cost and burden of chronic wounds on health systems
• Hull’s infrastructure push and multi-sector partnerships
• Emerging therapies including 3D bioprinting and buffy coat therapy
• Diabetes related factors and infection as key wound healing barriers

Overview of the chronic wound burden

The podcast focuses on chronic wounds as a major and underappreciated problem in modern healthcare, contributing to high costs and reduced quality of life. It notes that many wounds are downstream of conditions like diabetes and obesity, and that despite billions spent, healing remains incomplete. The UK Government and academic institutions are responding by funding new infrastructure to accelerate understanding and treatment, moving from passive wound care to active diagnostics and therapies.

Hull Wound Innovation Institute: a new hub for scale

Matt Hardman, the institute’s director, explains how Hull is uniting academics, clinicians and industrial partners to tackle wound care with “under the skin” science. The UK government has provided about £16 million for infrastructure, with additional leverage from industry and NHS partners. The funded infrastructure has included £12 million worth of equipment and refurbished laboratories. The university is also investing in people to recruit world leading experts to expand research capacity and throughput, aiming to deliver tangible improvements in patient care.

Diabetes, foot ulcers and the barriers to healing

Professor Cayton Dattaria highlights three major factors that increase risk for diabetic wounds: neuropathy (loss of sensation in the feet), vascular disease (poor blood supply), and impaired immune function due to hyperglycemia. These factors create a “perfect storm” where wounds persist, heal slowly, or become infected, sometimes leading to amputation with serious mortality implications. The discussion clarifies that wound biology in diabetes differs from normal healing and requires specific strategies tailored to infection, blood supply, pressure management and immune function.

Current and emerging therapeutic avenues

The program outlines a spectrum of interventions beyond dressings: pressure relief, improved circulation (including vascular surgery), infection control, and sharp debridement. It reviews existing, modestly effective approaches and points to promising but not yet standard therapies such as 3D bioprinting to actively promote healing, new bioscaffold materials, and biofilm-targeted antimicrobials. Buffy coat therapies, which concentrate infection fighting cells from a patient’s blood, can boost healing by roughly 50% but face practical barriers in busy clinical settings due to processing time and cost. The Hull institute is actively pursuing ways to streamline such approaches to fit routine care.

Diagnostics, host biology and predictive modeling

A key theme is the need for diagnostics that identify the pathology of individual wounds. Sequencing of wound microbiomes and host response profiling could allow targeted antimicrobial use and personalized therapies. The podcast emphasizes the role of biofilms, immune cell dynamics, and senescence in chronic wounds. Predictive modeling and computational approaches are highlighted as essential steps before clinical translation, enabling researchers to test hypotheses and design robust clinical pathways.

Future directions and translation to care

The episode argues that progress will come from research that is clinically informed, patient-centered, and infrastructure-enabled. It underscores the importance of genomics and omics technologies to understand causative factors and to tailor interventions. It also highlights the global dimension of wound care disparities, suggesting that lessons learned in the UK can inform wound care practices worldwide. The podcast closes by reinforcing the role of multidisciplinary collaboration in turning laboratory advances into real-world improvements in healing, prevention, and patient outcomes.